(Q33905877)

29 July 2017

title

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

Jeanette J McCarthy

1

1 reference

29 July 2017

Josephine H Li

2

1 reference

29 July 2017

Alexander Thompson

3

1 reference

29 July 2017

Sunil Suchindran

4

1 reference

29 July 2017

Xiang Qian Lao

5

1 reference

29 July 2017

Keyur Patel

6

1 reference

29 July 2017

Hans L Tillmann

7

1 reference

29 July 2017

Andrew J Muir

8

1 reference

29 July 2017

John G McHutchison

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

19 February 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

138

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

2307-2314

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Global burden of disease (GBD) for hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

A comparison of goodness-of-fit tests for the logistic regression model

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Lambda interferon inhibits hepatitis B and C virus replication

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Statistical analysis of molecular epidemiology studies employing case-series.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883666

Allelic discrimination using fluorogenic probes and the 5' nuclease assay

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20176026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20176026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1053/J.GASTRO.2010.02.009

1 reference

29 July 2017

1 reference

29 July 2017

1 reference